Synthetic control arms in clinical trials: Making it happen
Posted:
Can combining #AI tech & #RWD hold the key to overcoming challenges in #clinicaltrial design?
Join Sensyne Health on 24th February 2:00 p.m. GMT as experts discuss the application of #SyntheticControlArms – a new way of approaching clinical trials.
Sanome has secured Class IIb CE certification and MHRA approval for MEMORI - an AI-enabled warning system for the early prediction/prevention of healthcare‑associated infections (HAIs).
Read more here.
Driven by demand, Conexen are hoping to launch a new community in Manchester this October. They have an amazing team of local executives ready to go and excited to bring everybody in life sciences, biopharma and health together.
Contact them:…
Attendees
Sponsors and Exhibitors
Contact us